GSK Ebola vaccine fast-tracked into U.S., UK and African trials
August 28, 2014 at 05:59 AM EDT
LONDON, Aug 28 (Reuters) - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build up a stockpile of up to 10,000 doses for emergency deployment, if results are good.
